ZA972746B - Novel 2,3-benzodiazepine derivatives - Google Patents

Novel 2,3-benzodiazepine derivatives

Info

Publication number
ZA972746B
ZA972746B ZA972746A ZA972746A ZA972746B ZA 972746 B ZA972746 B ZA 972746B ZA 972746 A ZA972746 A ZA 972746A ZA 972746 A ZA972746 A ZA 972746A ZA 972746 B ZA972746 B ZA 972746B
Authority
ZA
South Africa
Prior art keywords
alkyl
cycloalkyl
benzodiazepine derivatives
novel
alkoxy
Prior art date
Application number
ZA972746A
Other languages
English (en)
Inventor
Ling Istvan
Abraham Gizella
Berzsenyi Pal
Tarnawa Istvan
Solyom Sandor
Andrasi Ferenc
Hamori Tamas
Csuzdi Emese
Horvath Katalin
Gal Melinda
Moravcsik Imre
Szollosy Marta
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9600871A external-priority patent/HU9600871D0/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ZA972746B publication Critical patent/ZA972746B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA972746A 1996-04-04 1997-04-01 Novel 2,3-benzodiazepine derivatives ZA972746B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9600871A HU9600871D0 (en) 1996-04-04 1996-04-04 New 2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ZA972746B true ZA972746B (en) 1998-10-09

Family

ID=89993864

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA972746A ZA972746B (en) 1996-04-04 1997-04-01 Novel 2,3-benzodiazepine derivatives

Country Status (11)

Country Link
KR (1) KR970069997A (es)
AT (1) ATE254608T1 (es)
AU (1) AU720745B2 (es)
BE (1) BE1010962A4 (es)
DE (1) DE59711013D1 (es)
ES (1) ES2127699B1 (es)
IT (1) IT1290453B1 (es)
NZ (1) NZ314517A (es)
UA (1) UA45358C2 (es)
YU (1) YU13197A (es)
ZA (1) ZA972746B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU208429B (en) * 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity
EP0771198B1 (en) * 1994-08-31 2002-02-06 Eli Lilly And Company Dihydro-2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
ES2127699B1 (es) 2000-01-16
YU13197A (sh) 1999-09-27
ITMI970776A1 (it) 1998-10-04
AU1773497A (en) 1997-10-09
KR970069997A (ko) 1997-11-07
AU720745B2 (en) 2000-06-08
UA45358C2 (uk) 2002-04-15
ATE254608T1 (de) 2003-12-15
NZ314517A (en) 2000-03-27
BE1010962A4 (fr) 1999-03-02
ES2127699A1 (es) 1999-04-16
IT1290453B1 (it) 1998-12-03
DE59711013D1 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
GB9514473D0 (en) Chemical compounds
PL334561A1 (en) Novel phtalysinones
SI0995743T1 (en) Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans
ATE172735T1 (de) Tropyl 7-azaindol-3-ylcarboxamide als antitussivum
CY2509B1 (en) New thiazole derivatives with phosphodiesterase-inhibitting effect
MXPA02012659A (es) Derivados de pirazindiona condensados.
CY2472B1 (en) Substituted dihydrobenzofurans as pde inhibitors.
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.
BG105539A (en) Eletriptan hydrobromide monohydrate
DE69317651D1 (en) Indol derivate als steroid 5 alpha-reductase inhibitoren
ZA972746B (en) Novel 2,3-benzodiazepine derivatives
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
MY107311A (en) Indenoindole compounds ii.
BG105249A (en) Fkbp inhibitors
BG106937A (en) Novel indole derivatives
MXPA02012472A (es) Compuestos quimicos.
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
HUP9700688A2 (hu) Új 2,3-benzodiazepin-származékok és ilyen hatóanyagot tartalmazó gyógyszerkészítmények
DE69803648D1 (de) Metalloproteaseinhibitoren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ES8401066A1 (es) Derivados de isoquinolina 1,5-sustituidos.
TW282458B (es)
ZA942970B (en) Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents.
WO2000008005A3 (de) Piperazinonderivate